Liposomal Bupivacaine in Rotator Cuff Repair

Completed · Phase 4

Conditions studied: Rotator Cuff Injury

In brief

To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter.

Key facts

Study ID

NCT03738696

Run by

University of Alabama at Birmingham

People needed

64

Starts

2019-12-15

Expected to finish

2022-01-01

Last updated by the study team

2024-05-16

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing outpatient arthroscopic rotator cuff repair
• Greater than or equal to 19 years of age at the time of surgery

You may not qualify if…

• Planned operative fixation of the biceps tendon or acromioclavicular joint
• Opioid use 6 weeks before surgery
• Gabapentin use 6 weeks before surgery
• History of prior shoulder surgery on the operative limb
• Severe pulmonary dysfunction
• Diagnosis of chronic pain, fibromyalgia or other somatosensory disorder(s)
• History of radicular pain or neuropathy in the operative limb
• Patients who are currently incapacitated for medical decision making

Where it is running

• UAB Hospital-Highlands — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.